欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号UK/H/5611/004
药品名称Ceftazidime Hospira 2 g Powder for Solution for Injection
活性成分
    • Ceftazidime 2.0 mg
剂型Powder for solution for injection
上市许可持有人Hospira UK Limited Hospira UK Ltd. Queensway, Royal Leamington Spa, Warwickshire, CV31 3RW United Kingdom
参考成员国 - 产品名称United Kingdom (UK)
Ceftazidime Hospira 2 g Powder for Solution for Injection
互认成员国 - 产品名称
    • Bulgaria (BG)
许可日期2015/08/17
最近更新日期2020/04/29
药物ATC编码
    • J01DD02 ceftazidime
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase